Literature DB >> 3001280

[3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site.

J B Cheng, E I Cheng, F Kohi, R G Townley.   

Abstract

Intact human granulocytes contain a leukotriene (LT) B4 receptor binding site, but the limited supply of these cells could adversely affect further progress of the study of this receptor. To select a tissue homogenate rich for this site, we have characterized the binding of highly specific [3H]LTB4 to guinea-pig spleen membranes and we have determined the ability of LTB4 to compete with [3H]LTB4 for binding sites in the membranes of 10 nonspleen tissues. In the spleen membrane, MgCl2 and CaCl2 enhanced [3H]LTB4 binding, but NaCl and KCl decreased it. Spleen [3H] LTB4 binding was a function of protein concentration and was rapid, reversible, stereoselective and saturable. Kinetic analyses showed that the rate constant for association and dissociation at 25 degrees C was 0.47 nM-1 min-1 and 0.099 min-1, respectively. A Scatchard plot of the data of the equilibrium experiment resulted a straight line with a dissociation constant of 1.8 nM and a density of 274 fmol/mg of protein. Moreover, the LTB4/[3H]LTB4 competition study performed at 4 or 25 degrees C revealed the inhibitory constant (Ki) of LTB4 to be in the nanomolar range. The rank order of agents competing for spleen [3H]LTB4 binding was: LTB4 (Ki = 2.8 nM) greater than 20-hydroxy-LTB4 (23 nM) greater than LTA4 (48 nM) greater than LTA4 methyl ester (0.13 microM) greater than 20-carboxy-LTB4 (greater than 6.6 microM) greater than or equal to arachidonic acid (0.15mM) = FPL-55,712 and FPL-57,231 (0.1-0.2 mM). Competition studies further indicated that felodipine, a 1,4-dihyropyridine Ca++ channel blocker, exhibited micromolar inhibition of spleen [3H]LTB4 binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001280

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.

Authors:  H J Showell; R Breslow; M J Conklyn; G P Hingorani; K Koch
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  cDNA cloning and characterization of guinea-pig leukotriene B4 receptor.

Authors:  K Masuda; T Yokomizo; T Izumi; T Shimizu
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

3.  Transition of affinity states for leukotriene B4 receptors in sheep lung membranes.

Authors:  B Votta; S Mong
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

4.  Characterization of the soluble leukotriene B4 receptor from sheep lung membranes.

Authors:  B Votta; J Keefer; S Mong
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

5.  Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.

Authors:  R J Griffiths; E R Pettipher; K Koch; C A Farrell; R Breslow; M J Conklyn; M A Smith; B C Hackman; D J Wimberly; A J Milici
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.